Glenmark-Favipiravir

Photo: The Logical Indian

Adding Umifenovir Doesn't Enhance Efficacy Of Favipiravir Drug Regimen

Adding antiviral Umifenovir in Favipiravir drug regimen does not enhance the effectiveness of the latter, asserted Glenmark Pharmaceuticals on October 9. Reportedly, the pharmaceutical company had conducted clinical trials to determine the efficacy of addition of Umifenovir against mono-therapy of Favipiravir tablets. Earlier, Glenmark had conducted clinical trials to determine the use of Favipiravir for COVID-19 treatment and had eventually… read-more

Sat, 10 Oct 2020 - 11:55 AM / by Sneha Ramesh

Tags: glenmark pharmaceuticals, Covid-19, coronavirus treatment, Favipiravir

Courtesy: The Economic Times

Favipiravir

Photo: The Print

Favipiravir Tablet to be Available in 400mg for COVID-19 Treatment

BDR Pharmaceuticals has planned to launch 400mg Favipiravir tablets after approval from DCGI. It will cost Rs 990 for a strip of 10 'Favipiravir 400 mg' tablets. The Favipiravir tablets are currently available in 200 mg and are being used to treat COVID-19 patients with 'mild-symptoms'. "Introducing a higher… read-more

Sun, 06 Sep 2020 - 08:33 AM / by Sneha Ramesh

Tags: Indian Pharma, Coronavirus, Covid-19, Favipiravir

Courtesy: The Economic Times